Mechanism of transcriptional regulation of LRP16 gene expression by 17-β estradiol in MCF-7 human breast cancer cells

Journal of Molecular Endocrinology

Volumn 34, Issue 1, 2005, Pages 77-89

  Zhao, Y L ^a   Han, W D ^a   Li, Q ^a   Mu, Yi Ming ^a   Lu, X C ^a   Yu, L ^a   Song, H J ^a   Li, X ^a   Lu, J M ^a   Pan, C Y ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; LUCIFERASE;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CHROMATIN; DNA BINDING; DNA FLANKING REGION; E BOX ELEMENT; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; REPORTER GENE; RNA TRANSLATION; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STUDENT T TEST; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BINDING SITES; BREAST NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR;

EID: 20044373450     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01628     Document Type: Article

References (53)

1. Abdelrahim M, Samudio I, Smith R, Burghardt R & Safe S 2002 Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. Journal of Biological Chemistry 277 28815-28822.
2. Augereau P, Miralles F, Cavailles V, Gaudelet C, Parker M & Rochefort H 1994 Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Molecular Endocrinology 8 693-703.
3. Briand P & Lykkesfeldt AE 2001 An in vitro model of human breast carcinogenesis: epigenetic aspects. Breast Cancer Research and Treatment 65 179-187.
4. Briggs MR, Kadonaga JT, Bell SP & Tjian R 1986 Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234 47-52.
5. Brooks SC, Locke ER & Soule HD 1973 Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. Journal of Biological Chemistry 248 6251-6253.
6. Castro-Rivera E, Samudio I & Safe S 2001 Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. Journal of Biological Chemistry 276 30852-30861.
7. Cavailles V, Augereau P & Rochefort H 1993 Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. PNAS 90 203-207.
8. Chow J, Tobias JH, Colston KW & Chambers TJ 1992 Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. Journal of Clinical Investigation 89 74-78.
9. Dickson RB & Lippman ME 1995 Growth factors in breast cancer. Endocrinology Reviews 16 559-589.
10. Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C & Safe S 1999 Mechanisms of transcriptional activation of bcl-2 gene expression by 17 beta-estradiol in breast cancer cells. Journal of Biological Chemistry 274 32099-32107.
11. Driscoll MD, Sathya G, Muyan M, Klinge CM, Hilf R & Bambara RA 1998 Sequence requirements for estrogen receptor binding to estrogen response elements. Journal of Biological Chemistry 273 29321-29330.
12. Dubik D, Dembinski TC & Shiu RP 1987 Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Research 47 6517-6521.
13. Dynan WS & Tjian R 1983 The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35 78-87.
14. Elnitski L, Miller W & Hardison R 1997 Conserved E boxes function as part of the enhancer in hypersensitive site 2 of the beta-globin locus control region. Role of basic helix-loop-helix proteins. Journal of Biological Chemistry 272 369-378.
15. Farhat MY, Lavigne MC & Ramwell PW 1996 The vascular protective effects of estrogen. FASEB Journal 10 615-624.
16. Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, Der CJ, Tamanoi F, Andres DA & Perou CM 2001 RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. Journal of Biological Chemistry 276 42259-42267.
17. Gao E, Wang Y, Alcorn JL & Mendelson CR 1997 The basic helix-loop-helix-zipper transcription factor USF1 regulates expression of the surfactant protein-A gene. Journal of Biological Chemistry 272 23398-23406.
18. Gidoni D, Dynan WS & Tjian R 1984 Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature 312 409-413.
19. Gupta MP, Amin CS, Gupta M, Hay N & Zak R 1997 Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Molecular Cell Biology 17 3924-3836.
20. Han WD, Lou FD, Yu L, Wang QS, Han XP & Li XJ 2002 SAGE pattern of LRP16 gene and its expression in normal blood and leukemic cells. Academic Journal of PLA Postgraduate Medical School 23 161-163.
21. Han WD, Mu YM, Lu XC, Li XJ, Yu L, Song HJ, Li M, Lu JM, Zhao YL & Pan CY 2003a Up-regulation of LRP16 mRNA by 17β-estradiol through activation of estrogen receptor α (αRα), but not estrogen receptor β (αRβ), promotes human breast cancer MCF-7 cell proliferation: a preliminary report. Endocrine-Related Cancer 10 215-222.
22. Han WD, Li XL, Lu XC, Xu ZM, Yu L, Li M & Mu YM 2003b Effect of LRP16 on breast cancer MCF-7 cell proliferation. Chinese Journal of Biochemistry and Molecular Biology 19 672-676.
23. Hoffman PW & Chernak JM 1995 DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter. Nucleic Acids Research 23 2229-2235.
24. Karlseder J, Rotheneder H & Wintersberger E 1996 Interaction of Sp1 with growth- and cell cycle-regulated transcription factor E2F. Molecular Cell Biology 16 1659-1667.
25. Katzenellenbogen BS & Katzenellenbogen JA 2000 Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Research 2 335-344.
26. Khan S, Abdelrahim, M, Samudio I & Safe S 2003 Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17 beta-estradiol in breast cancer cells. Endocrinology 144 2325-2335.
27. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Research 29 2905-2919.
28. Krishnan V, Wang X & Safe S 1994 Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. Journal of Biological Chemistry 269 15912-15917.
29. Levenson AS & Jordan VC 1997 MCF-7: the first hormone-responsive breast cancer cell line. Cancer Research 5 73071-73078.
30. Li C, Briggs MR, Ahlborn TE, Kraemer FB & Liu J 2001 Requirement of Sp1 and estrogen receptor α interaction in 17β-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology 142 1546-1553.
31. Lin SY, Black AR, Kostic D, Pajovic D, Hoover CN & Azizkhan JC 1996 Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Molecular Cell Biology 16 1668-1675.
32. Lippman ME, Bolan G & Huff K 1975 Human breast cancer responsive to androgen in long term tissue culture. Nature 258 339-341.
33. Maekawa T, Sudo T, Kurimoto M & Ishii S 1991 USF-related transcription factor, HIV-TF1, stimulates transcription of human immunodeficiency virus-1. Nucleic Acids Research 19 4689-4694.
34. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ & Scanlan TS 1997 Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277 1508-1510.
35. Petz LN & Nardulli AM 2000 Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Molecular Endocrinology 14 972-985.
36. Petz LN, Ziegler YS, Loven MA & Nardulli AM 2002 Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 143 4583-4591.
37. Petz LN, Ziegler YS, Schultz JR, Kim H, Kemper JK & Nardulli AM 2004 Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites. Journal of Steroid Biochemistry and Molecule Biology 88 113-122.
38. Porter W, Wang F, Wang W, Duan R & Safe S 1996 Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Molecular Endocrinology 10 1371-1378.
39. Porter W, Saville B, Hoivik D & Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Molecular Endocrinology 11 1569-1580.
40. Qin C, Nguyen T, Stewart J, Samudio I, Burghardt R & Safe S 2002 Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor kappaB/CCAAT-binding transcription factor-1 complex. Molecular Endocrinology 16 1793-1809.
41. Safe S 2001 Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitamins and Hormones - Advances in Research and Applications 62 231-252.
42. Samudio I, Vyhlidal C, Wang F, Stoner M, Chen I, Kladde M, Barhoumi R, Burghardt R & Safe S 2001 Transcriptional activation of deoxyribonucleic acid polymerase alpha gene expression in MCF-7 cells by 17 beta-estradiol. Endocrinology 142 1000-1008.
43. Scholtz B, Kingsley-Kallesen M & Rizzino A 1996 Transcription of the transforming growth factor-beta2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene. Journal of Biological Chemistry 271 32375-32380.
44. Scholz A, Truss M & Beato M 1998 Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium. Journal of Biological Chemistry 273 4360-4366.
45. Soule HD, Vazguez J, Long A, Albert S & Brennan M 1973 A human cell line from a pleural effusion derived from a breast carcinoma. Journal of the National Cancer Institute 51 1409-1416.
46. Sun G, Porter W & Safe S 1998 Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex. Molecular Endocrinology 12 882-890.
47. Turner RT, Riggs BL & Spelsberg TC 1994 Skeletal effects of estrogen. Endocrinology Reviews 15 275-300.
48. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R & Friend SH 2002 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 530-536.
49. Vyhlidal C, Samudio I, Kladde M & Safe S 2000 Transcriptional activation of transforming growth factor α by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. Journal of Molecular Endocrinology 24 329-338.
50. Watson PH, Pon RT & Shiu RP 1991 Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Research 51 3996-4000.
51. Xie W, Dnau R, Chen I, Samudio I & Safe S 2000 Transcriptional activation of thymidylate synthase by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology 141 2439-2449.
52. Xing W & Archer TK 1998 Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Molecular Endocrinology 12 1310-1321.
53. Yu L, Han WD, Lou FD, Wang QS & Zhao Y 2000 Cloning of leukemia associated gene LRP16 in acute myeloid leukemia. Academic Journal of PLA Postgraduate Medical School 21 81-84.